Insofar as tics in TS are triggered by an aberrant reward drive to release a tic, this effect of PDE10A inhibition, if mechanism rather than drug specific, may contribute a unique component to efficacy in addition to the more direct suppression of tic release. The gene discussed is PDE10A; the disease is Tics.